Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Rapamycin increases survival in ALS mice lacking mature lymphocytes.

Staats KA, Hernandez S, Schönefeldt S, Bento-Abreu A, Dooley J, Van Damme P, Liston A, Robberecht W, Van Den Bosch L.

Mol Neurodegener. 2013 Sep 11;8:31. doi: 10.1186/1750-1326-8-31.

2.

Autophagy, lithium, and amyotrophic lateral sclerosis.

Pasquali L, Longone P, Isidoro C, Ruggieri S, Paparelli A, Fornai F.

Muscle Nerve. 2009 Aug;40(2):173-94. doi: 10.1002/mus.21423. Review.

PMID:
19609902
3.

Targeting autophagy in ALS: a complex mission.

Nassif M, Hetz C.

Autophagy. 2011 Apr;7(4):450-3. Epub 2011 Apr 1.

PMID:
21252621
4.

Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS.

Bhattacharya A, Bokov A, Muller FL, Jernigan AL, Maslin K, Diaz V, Richardson A, Van Remmen H.

Neurobiol Aging. 2012 Aug;33(8):1829-32. doi: 10.1016/j.neurobiolaging.2011.06.002. Epub 2011 Jul 18.

PMID:
21763036
5.

Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43.

Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ, Shen CK.

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15024-9. doi: 10.1073/pnas.1206362109. Epub 2012 Aug 29.

6.

Autophagy and Its Comprehensive Impact on ALS.

Song CY, Guo JF, Liu Y, Tang BS.

Int J Neurosci. 2012 Dec;122(12):695-703. doi: 10.3109/00207454.2012.714430. Epub 2012 Sep 3. Review.

PMID:
22827270
7.
8.

Neuroprotective effects of autophagy induced by rapamycin in rat acute spinal cord injury model.

Wang ZY, Liu WG, Muharram A, Wu ZY, Lin JH.

Neuroimmunomodulation. 2014;21(5):257-67. doi: 10.1159/000357382. Epub 2014 Mar 1.

PMID:
24603048
9.

Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.

Edri-Brami M, Rosental B, Hayoun D, Welt M, Rosen H, Wirguin I, Nefussy B, Drory VE, Porgador A, Lichtenstein RG.

PLoS One. 2012;7(5):e35772. doi: 10.1371/journal.pone.0035772. Epub 2012 May 30.

10.

Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes.

Bachar-Wikstrom E, Wikstrom JD, Ariav Y, Tirosh B, Kaiser N, Cerasi E, Leibowitz G.

Diabetes. 2013 Apr;62(4):1227-37. doi: 10.2337/db12-1474. Epub 2012 Dec 28.

11.

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, Przedborski S, Gendelman HE.

PLoS One. 2008 Jul 23;3(7):e2740. doi: 10.1371/journal.pone.0002740.

12.

Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS.

Hefferan MP, Johe K, Hazel T, Feldman EL, Lunn JS, Marsala M.

Cell Transplant. 2011;20(8):1153-61. doi: 10.3727/096368910X564553. Epub 2011 Jun 9.

PMID:
21669047
13.

Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis.

Engelhardt JI, Tajti J, Appel SH.

Arch Neurol. 1993 Jan;50(1):30-6.

PMID:
8093428
14.

Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice.

Wang S, Guan Y, Chen Y, Li X, Zhang C, Yu L, Zhou F, Wang X.

Biotechnol Lett. 2013 Aug;35(8):1199-207. doi: 10.1007/s10529-013-1199-1. Epub 2013 Apr 4.

PMID:
23553522
15.

A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.

Tanaka K, Okada Y, Kanno T, Otomo A, Yanagisawa Y, Shouguchi-Miyata J, Suga E, Kohiki E, Onoe K, Osuga H, Aoki M, Hadano S, Itoyama Y, Ikeda JE.

Exp Neurol. 2008 Jun;211(2):378-86. doi: 10.1016/j.expneurol.2008.02.004. Epub 2008 Mar 4.

PMID:
18423451
16.

Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis.

Sasaki S.

J Neuropathol Exp Neurol. 2011 May;70(5):349-59. doi: 10.1097/NEN.0b013e3182160690.

PMID:
21487309
17.

Clinical testing and spinal cord removal in a mouse model for amyotrophic lateral sclerosis (ALS).

Günther R, Suhr M, Koch JC, Bähr M, Lingor P, Tönges L.

J Vis Exp. 2012 Mar 17;(61). pii: 3936. doi: 10.3791/3936.

18.

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.

Neymotin A, Petri S, Calingasan NY, Wille E, Schafer P, Stewart C, Hensley K, Beal MF, Kiaei M.

Exp Neurol. 2009 Nov;220(1):191-7. doi: 10.1016/j.expneurol.2009.08.028. Epub 2009 Sep 4.

19.

Autophagy activation by rapamycin eliminates mouse Mallory-Denk bodies and blocks their proteasome inhibitor-mediated formation.

Harada M, Hanada S, Toivola DM, Ghori N, Omary MB.

Hepatology. 2008 Jun;47(6):2026-35. doi: 10.1002/hep.22294.

PMID:
18454506
20.

Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.

Zhao W, Beers DR, Liao B, Henkel JS, Appel SH.

Neurobiol Dis. 2012 Dec;48(3):418-28. doi: 10.1016/j.nbd.2012.07.008. Epub 2012 Jul 17.

Supplemental Content

Support Center